Bionacom manufactures ultra-pure silica and polymer-based HPLC columns for pharmaceutical QC, biopharmaceutical analysis, food safety, and environmental testing. Every column is produced to a defined specification — and traceable to it.
Our columns are produced under strict quality control protocols, using ultra-pure silica substrates with very low metal content — because trace metals are the leading cause of peak tailing for basic analytes.
Every porous silica used in our columns meets stringent purity thresholds for trace metals — Fe, Al, Na below 10 ppm — ensuring inertness toward chelating analytes and low silanol activity.
Our reversed-phase, ion-exchange, and specialty columns are classified to USP L-codes, enabling direct drop-in use in pharmacopoeial methods including USP, EP, JP, ChP, and BP assays.
A single bonded phase is available across particle sizes from 1.7 µm to 15 µm, and inner diameters from 2.1 mm to 50 mm — enabling linear method transfer from UHPLC screening to preparative purification.
300 Å and 1000 Å pore variants are available for reversed-phase and core-shell phases, enabling intact protein, antibody, and oligonucleotide separations without secondary adsorption effects.
From C1 to C30, phenyl to pentafluorophenyl, SCX to Protein A affinity — 13 distinct product families cover every separation mode used in modern analytical laboratories, minimising the need for multiple suppliers.
As the manufacturer, Bionacom can discuss production specifications, OEM arrangements, and custom column configurations directly — without intermediary timelines or minimum orders enforced by a distributor tier.
Each series targets a distinct separation mode or analytical need — from general reversed-phase work in pharmaceutical QC to size-exclusion and affinity columns for biopharmaceutical characterisation.
Search by name, phase, or application keyword. Filter by product series.
| Column | Series | Particle (µm) | Pore (Å) | pH range | USP | Max. T (°C) |
|---|
Bionacom columns are validated across the most demanding analytical sectors. Application examples are provided for each column in the full catalogue.
Method development and QC release for APIs, impurity profiling, dissolution testing, and pharmacopoeial assays. Columns from C1 to C30, with USP L-code specifications throughout.
Monoclonal antibody characterisation (SEC, HIC, Protein A), peptide mapping, oligonucleotide purity, and biosimilar comparability studies using wide-pore core-shell and polymer-based columns.
Pesticide residues, veterinary drug residues, mycotoxins, food colourants, preservatives, vitamins, and sugar profiles. BioSugar ligand-exchange series for carbohydrate quantification.
PAHs, phenols, herbicides, pesticides, and emerging contaminants in water and soil matrices. Complementary selectivities — C18, PFP, CN — for congener discrimination.
Standardisation of herbal extracts and multi-component TCM preparations — an application area specifically verified across multiple Bionacom reversed-phase and polar-embedded column types.
Molecular weight distribution by GPC/SEC (BioGPC series, organic solvents), and polyelectrolyte characterisation by aqueous SEC (BioSEC-PMMA) across pH 1–14.
Formulation analysis and active substance quantification for pesticides, herbicides, and fertiliser components. Specific validation examples include glyphosate, DDT, and macrolide residue methods.
BioSil Prep series columns in 10–50 mm I.D. for preparative isolation of pharmaceutical intermediates, natural product fractions, and peptide purification up to process scale.
Contact Bionacom or your regional distributor for pricing, availability, and technical consultation.